Citadel Advisors’s OncoSec Medical Incorporated ONCS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-711
| Closed | -$8K | – | 7301 |
|
|
2022
Q3 | $8K | Sell |
711
-1,686
| -70% | -$19K | ﹤0.01% | 5672 |
|
|
2022
Q2 | $39K | Buy |
2,397
+1,074
| +81% | +$17.5K | ﹤0.01% | 5573 |
|
|
2022
Q1 | $33K | Sell |
1,323
-510
| -28% | -$12.7K | ﹤0.01% | 6039 |
|
|
2021
Q4 | $39K | Buy |
1,833
+369
| +25% | +$7.85K | ﹤0.01% | 6223 |
|
|
2021
Q3 | $68K | Buy |
1,464
+983
| +204% | +$45.7K | ﹤0.01% | 6026 |
|
|
2021
Q2 | $30K | Sell |
481
-333
| -41% | -$20.8K | ﹤0.01% | 6293 |
|
|
2021
Q1 | $86K | Buy |
814
+224
| +38% | +$23.7K | ﹤0.01% | 5923 |
|
|
2020
Q4 | $84K | Buy |
590
+78
| +15% | +$11.1K | ﹤0.01% | 4734 |
|
|
2020
Q3 | $38K | Sell |
512
-593
| -54% | -$44K | ﹤0.01% | 4437 |
|
|
2020
Q2 | $50K | Buy |
+1,105
| New | +$50K | ﹤0.01% | 4381 |
|
|
2019
Q3 | – | Sell |
-594
| Closed | -$33K | – | 5439 |
|
|
2019
Q2 | $33K | Buy |
+594
| New | +$33K | ﹤0.01% | 4427 |
|
|
2019
Q1 | – | Sell |
-155
| Closed | -$22K | – | 5317 |
|
|
2018
Q4 | $22K | Buy |
+155
| New | +$22K | ﹤0.01% | 4252 |
|
|
2018
Q3 | – | Sell |
-49
| Closed | -$15K | – | 4975 |
|
|
2018
Q2 | $15K | Buy |
+49
| New | +$15K | ﹤0.01% | 4084 |
|
|
2017
Q4 | – | Sell |
-126
| Closed | -$27K | – | 4485 |
|
|
2017
Q3 | $27K | Buy |
126
+57
| +83% | +$12.2K | ﹤0.01% | 3485 |
|
|
2017
Q2 | $18K | Sell |
69
-53
| -43% | -$13.8K | ﹤0.01% | 3534 |
|
|
2017
Q1 | $34K | Buy |
+122
| New | +$34K | ﹤0.01% | 3459 |
|